Evidence map›Paper›PMID 35310021›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Toxicity, Anti-Inflammatory, and Antioxidant Activities of Cubiu (

Jéssica Franco Dalenogare, Marina de Souza Vencato, Greice Franciele Feyh Dos Santos Montagner, Thiago Duarte, Marta Maria Medeiros Frescura Duarte, Camila Camponogara, Sara Marchesan Oliveira, Marcelo Leite da Veiga, Maria Izabel de Ugalde Marques da Rocha, Maria Amália Pavanato and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jéssica Franco DalenogareDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-5030-880X
Marina de Souza VencatoDepartment of Morphology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-5787-0790
Greice Franciele Feyh Dos Santos MontagnerDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0001-8765-1452
Thiago DuarteDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-3219-3586
Marta Maria Medeiros Frescura DuarteDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0003-4371-4989
Camila CamponogaraDepartment of Biochemistry, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0003-0283-7931
Sara Marchesan OliveiraDepartment of Biochemistry, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0003-2960-5284
Marcelo Leite da VeigaDepartment of Morphology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-9303-3324
Maria Izabel de Ugalde Marques da RochaDepartment of Morphology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-3461-8082
Maria Amália PavanatoDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0002-1348-3828
Liliane de Freitas BauermannDepartment of Physiology and Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.ORCID https://orcid.org/0000-0003-2340-0501
Universidade Federal de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cubiu, an Amazonian fruit, is widely used as food and popular treatment for pathologies that present an inflammatory pattern, such as skin wound healing. However, there is still no confirmation in the scientific literature about the safety profile, as well as the anti-inflammatory, antioxidant, and healing actions of cubiu. This study is divided into two experimental protocols using Wistar rats. Thus, the first objective (protocol 1) of this study was to evaluate the toxicity of an oral administration of cubiu extract at different doses for 28 days. The macroscopic and microscopic analyses of the liver and kidney were performed, and the following analysis was determined in plasma: glutamic oxaloacetic transaminase, glutamic pyruvic transaminase, gamma-glutamyl transpeptidase, glucose, triglycerides, total cholesterol, urea, creatinine, and uric acid. After, we conducted the second protocol aimed to establish the potential antioxidant and anti-inflammatory capacity of cubiu and its interaction with magnetic field in skin wound healing. On days 3, 7, and 14 of treatment, skin and blood samples were collected and analyzed: the oxidative stress biomarkers (reactive substances to thiobarbituric acid, nonprotein thiols, superoxide dismutase, catalase, and glutathione S-transferase), myeloperoxidase enzymatic activity, and cytokines levels (interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor-alpha). The cubiu has shown to be safe and nontoxic. Both cubiu and magnetic field promoted decreased levels of proinflammatory and prooxidant biomarkers (interleukin 1, interleukin 6, tumor necrosis factor-alpha, and reactive substances to thiobarbituric acid), as well as increased levels of anti-inflammatory and antioxidant biomarkers (interleukin 10, nonprotein thiols, and superoxide dismutase), with greater potential when treatments are used in association. Thus, cubiu promotes antioxidant and anti-inflammatory action in skin wound healing, while also improving results of the conventional treatment for skin healing (magnetic field) when used in association.

Identifiers

PMID35310021
PMCPMC8930208
OpenAlexW4221004581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.